# data[].attributes.body
These are the treatment that work for people that have Cystic fibrosis. Each one work differntly for everyone

# data[].attributes.body
The exact name of Cystic Fibrosis is mucoviscidosis.

# data[].attributes.body
To inherit Cystic fibrosis you must inherit one copy of a CFTR gene that contains mutations from each parent. If only one parent carries the gene there's still an increased chance to get Cystic fibrosis. If a parent has a child with Cystic fibrosis they only have a 25% chance to get another child with the same disease.

# data[].attributes.attachment_link.readable_text
Cystic fibrosis (CF) is a genetic disease. This means that CF is inherited. A child will be born with CF only if two CF genes are inherited - one from the mother and one from the father. A person who has only one CF gene is healthy and said to be a "carrier" of the disease. A carrier has an increased chance of having a child with CF. This type of inheritance is called "autosomal recessive." Autosomal means that the gene is on one of the first 22 pairs of chromosomes which do not determine gender, so that the disease equally affects males and females. "Recessive" means that two copies of the gene, one inherited from each parent, are necessary to have the condition. Once parents have had a child with CF, there is a one in four, or 25 percent, chance with each subsequent pregnancy for another child to be born with CF. This means that there is a three out of four, or 75 percent chance, for another child to not have CF.

The birth of a child with CF is often a total surprise to a family, since most of the time there is no previous family history of CF. Many autosomal recessive conditions occur this way. Since both parents are healthy, they had no prior knowledge that they carried the gene, nor that they passed the gene to the pregnancy at the same time.

Genes are founds on structures in the cells of our body called "chromosomes." There are normally 46 total, or 23 pairs of chromosomes in each cell of our body. The seventh pair of chromosomes contains a gene called the CFTR (cystic fibrosis transmembrane regulator) gene. Mutations or errors in this gene are what cause CF. This gene is quite large and complex. Over 1,000 different mutations in this gene have been found which cause CF.

The risk for having a mutation in the gene for CF depends on your ethnic background (for persons without a family history of CF):

Testing for the CF gene can be done from a small blood sample or from a "cheek swab," which is a brush rubbed against the inside of your cheek to obtain cells for testing. Laboratories generally test for the most common mutations, and most labs test for anywhere from 30 to 100 total mutations. The detection rate depends on the person's ethnic background. In general, the detection rate for the Caucasian population is around 90 percent, 97 percent or more for the Ashkenazi population, 57 percent for Hispanics, 75 percent for African-Americans, and 30 percent for Asians. The detection rate differs because CF is more common in certain geographical areas and certain populations of the world. The diagnosis is confirmed by another test call the sweat chloride test.

There are many people with CF whose mutations have not been identified. In other words, all of the genetic errors that cause the disease have not been discovered. Because not all mutations are detectable, a person can still be a CF carrier even if no mutations were found by carrier testing.

Testing for the CF gene is recommended for anyone who has a family member with the disease, or whose partner is a known carrier of CF or affected with CF.

Click here for a handout on the Genetics of Cystic Fibrosis from the CF Foundation.

# data[].attributes.attachment_link.description
Cystic fibrosis (CF) is a genetic disease. This means that CF is inherited. A child will be born with CF only if two CF genes are inherited - one from the mother and one from the father. A person who has only one CF gene is healthy and said to be a "carrier" of the disease.

# data[].attributes.body
The Cystic Fibrosis Foundation (CFF) is one of the organizations that is a voluntary and non-profit organization that promotes Cystic Fibrosis. The Cystic Fibrosis Foundation funds its own network for research at universities and medical schools. Established in 1955, this foundation has helped close to 40,000 children and adults with this disease.

# data[].attributes.attachment_link.provider_name
NORD (National Organization for Rare Disorders)

# data[].attributes.attachment_link.readable_text
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD's copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.

# data[].attributes.attachment_link.title
Cystic Fibrosis Foundation - NORD (National Organization for Rare Disorders)

# data[].attributes.attachment_link.description
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD.

# data[].attributes.body
Scientists reasearching Cystic Fibrosis have been working to find better, more affective, and a larger range of treatments. The National Heart, Lung, and Blood Institute (NHLBI) focuses on how changes occur in the CFTR protein to allow them to fine more medicine and treatments for this disease.

# data[].attributes.attachment_link.description
The NHLBI leads and supports research on cystic fibrosis to develop new treatments and ways to improve quality of life.